Tricyclic antidepressants for major depressive disorder: a comprehensive evaluation of current practice in the Netherlands

被引:10
作者
Vos, Cornelis F. [1 ,2 ]
Aarnoutse, Rob E. [3 ]
Op de Coul, Marijke J. M. [4 ]
Spijker, Jan [4 ,5 ]
Groothedde-Kuyvenhoven, Mascha M. [6 ,7 ]
Mihaescu, Raluca [8 ]
Wessels-Basten, Sonja J. W. [8 ]
Rovers, Jordy J. E. [9 ]
ter Hark, Sophie E. [1 ,2 ]
Schene, Aart H. [1 ,2 ]
Hulscher, Marlies E. J. L. [10 ]
Janzing, Joost G. E. [1 ,2 ]
机构
[1] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Reinier Postlaan 10, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen, Med Ctr, Dept Pharm Radboud Inst Hlth Sci, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen, Nijmegen, Netherlands
[5] Pro Persona, Nijmegen, Netherlands
[6] Deventer Hosp, Deventer, Netherlands
[7] Dimence Grp, Deventer, Netherlands
[8] Catharina Hosp, Eindhoven, Netherlands
[9] Vincent van Gogh Inst Psychiat, Venray, Netherlands
[10] Radboud Univ Nijmegen, Sci Ctr Qual Hlthcare, Med Ctr, Nijmegen, Netherlands
关键词
Antidepressant agents; Clinical practice guidelines; Qualitative approach; Major depressive disorder; Tricyclic antidepressants; GUIDELINES;
D O I
10.1186/s12888-021-03490-x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Traditionally tricyclic antidepressants (TCAs) have an important place in treatment of major depressive disorder (MDD). Today, often other antidepressant medications are considered as first step in the pharmacological treatment of MDD, mainly because they are associated with less adverse effects, whereby the position of TCAs appears unclear. In this study we aimed to examine the current practice of TCAs in treatment of unipolar MDD. Methods A mixed methods approach was applied. First, a selection of leading international and national guidelines was reviewed. Second, actual TCA prescription was examined by analyzing health records of 75 MDD patients treated with the TCAs nortriptyline, clomipramine or imipramine in different centers in the Netherlands. Third, promotors and barriers influencing the choice for TCAs and dosing strategies were explored using semi-structured interviews with 24 Dutch psychiatrists. Results Clinical practice guidelines were sometimes indirective and inconsistent with each other. Health records revealed that most patients (71%) attained therapeutic plasma concentrations within two months of TCA use. Patients who achieved therapeutic plasma concentrations reached them on average after 19.6 days (SD 10.9). Both health records and interviews indicated that therapeutic nortriptyline concentrations were attained faster compared to other TCAs. Various factors were identified influencing the choice for TCAs and dosing by psychiatrists. Conclusions Guideline recommendations and clinical practice regarding TCA prescription for MDD vary. To increase consistency in clinical practice we recommend development of an up-to-date guideline integrating selection and dosing of TCAs, including the roles of therapeutic drug monitoring and pharmacogenetics. Such a guideline is currently lacking and would contribute to optimal TCA treatment, whereby efficacy and tolerability may be increased.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder
    Yi-Yung Hung
    Kai-Wei Huang
    Hong-Yo Kang
    Gloria Ya-Ling Huang
    Tiao-Lai Huang
    Psychopharmacology, 2016, 233 : 1707 - 1714
  • [42] Association analysis of gut microbiota and efficacy of SSRIs antidepressants in patients with major depressive disorder
    Gao, Mingxue
    Tu, Hongwei
    Liu, Penghong
    Zhang, Yanyan
    Zhang, Ruiyu
    Jing, Lin
    Zhang, Kerang
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 330 : 40 - 47
  • [43] White matter integrity and medication response to antidepressants in major depressive disorder: a review of the literature
    Videtta, Giovanni
    Squarcina, Letizia
    Prunas, Cecilia
    Brambilla, Paolo
    Delvecchio, Giuseppe
    FRONTIERS IN PSYCHIATRY, 2024, 14
  • [44] Antidepressants normalize elevated Toll-like receptor profile in major depressive disorder
    Hung, Yi-Yung
    Huang, Kai-Wei
    Kang, Hong-Yo
    Huang, Gloria Ya-Ling
    Huang, Tiao-Lai
    PSYCHOPHARMACOLOGY, 2016, 233 (09) : 1707 - 1714
  • [45] Evaluation of periodontitis in hospital outpatients with major depressive disorder
    Solis, A. C. O.
    Marques, A. H.
    Pannuti, C. M.
    Lotufo, R. F. M.
    Lotufo-Neto, F.
    JOURNAL OF PERIODONTAL RESEARCH, 2014, 49 (01) : 77 - 84
  • [46] Development and evaluation of a multimodal marker of major depressive disorder
    Yang, Jie
    Zhang, Mengru
    Ahn, Hongshik
    Zhang, Qing
    Jin, Tony B.
    Li, Ien
    Nemesure, Matthew
    Joshi, Nandita
    Jiang, Haoran
    Miller, Jeffrey M.
    Ogden, Robert Todd
    Petkova, Eva
    Milak, Matthew S.
    Sublette, Mary Elizabeth
    Sullivan, Gregory M.
    Trivedi, Madhukar H.
    Weissman, Myrna
    McGrath, Patrick J.
    Fava, Maurizio
    Kurian, Benji T.
    Pizzagalli, Diego A.
    Cooper, Crystal M.
    McInnis, Melvin
    Oquendo, Maria A.
    Mann, Joseph John
    Parsey, Ramin V.
    DeLorenzo, Christine
    HUMAN BRAIN MAPPING, 2018, 39 (11) : 4420 - 4439
  • [47] Evaluation of Thiol/Disulfide Interrelation in Major Depressive Disorder
    Beginoglu, Ozlem
    Asoglu, Mehmet
    Sabuncu, Esat
    Celik, Hakim
    ALPHA PSYCHIATRY, 2023, 24 (06): : 283 - 287
  • [48] Tachyphylaxis in major depressive disorder: A review of the current state of research
    Kinrys, Gustavo
    Gold, Alexandra K.
    Pisano, Vincent D.
    Freeman, Marlene P.
    Papakostas, George I.
    Mischoulon, David
    Nierenberg, Andrew A.
    Fava, Maurizio
    JOURNAL OF AFFECTIVE DISORDERS, 2019, 245 : 488 - 497
  • [49] The molecular mechanism of polysaccharides in combating major depressive disorder: A comprehensive review
    Kong, Hongwei
    Xu, Tianren
    Wang, Shengguang
    Zhang, Zhiyuan
    Li, Min
    Qu, Suyan
    Li, Qinqing
    Gao, Peng
    Cong, Zhufeng
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 259
  • [50] A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia
    Abousheishaa, Aya Ahmed
    Sue-Yin, Low
    Khin, Kok Chee
    Sulaiman, Ahmad Hatim
    Huri, Hasniza Zaman
    Guan, Ng Chong
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (45B) : 405 - 411